08:30 - 09:00 µî·Ï
09:00 - 10:30 Symposium III: Adipokines
ÁÂÀå: À̹®±Ô (¼º±Õ°üÀÇ´ë), ¹Ú°æ¼ö (¼­¿ïÀÇ´ë)  
09:00 - 09:24 Inflammation in metabolic diseases
ÀÌ¿ø¿µ (¼º±Õ°üÀÇ´ë)  
09:24 - 09:48 Adipokines, Inflammation and atherosclerosis
Ãְ湬 (°í·ÁÀÇ´ë)  
09:48 - 10:12 New adipokines and hepatokines
ÃÖ¼ºÈñ (¼­¿ïÀÇ´ë)  
10:12 - 10:30 Q&A
Panel: ±è¼º·¡, È«Àº°æ, Çã±Ô¿¬  
10:30 - 11:00 Coffee Break - Æ÷½ºÅÍ ±¸¿¬
11:00 - 12:30 Symposium IV: Vascular Disease
ÁÂÀå: ½ÅÇöÈ£ (°üµ¿ÀÇ´ë), ¼­È«¼® (°í·ÁÀÇ´ë)  
11:00 - 11:18 Metabolic abnormality and inflammation in vascular disease
ÀÌ»óÇÐ (¿¬¼¼ÀÇ´ë)  
11:18 - 11:36 Rennin-angiotensin-aldosterone system in inflammation and atherosclerosis
ÀÌÇØ¿µ (¼­¿ïÀÇ´ë)  
11:36 - 11:54 Meaning of calcification in vascular disease
±èÀÀÁÖ (°í·ÁÀÇ´ë)  
11:54 - 12:12 Clinical trials of inflammation on atherosclerosis
±è¹Î±Ô (ÇѸ²ÀÇ´ë)  
12:12 - 12:30 Q&A
Panel: ±è¿ø, ¹ÚÁ¾¼±, ¹èÀåÈ£  
12:30 - 13:30 Luncheon Session
ÁÂÀå: ¹é»óÈ« (°¡Å縯ÀÇ´ë)   
12:30 - 13:30 Àû±ØÀûÀÎ ÁöÁú Á¶ÀýÀÇ ´ë»ó
ÇѱâÈÆ (¿ï»êÀÇ´ë)  
13:30 - 13:50 Coffee Break - Æ÷½ºÅÍ ±¸¿¬
13:50 - 14:30 Plenary Lecture
ÁÂÀå: ¹Ú¿µ¹è (¼­¿ïÀÇ´ë)   
13:50 - 14:30 Adiponectin and atherosclerosis
Toshimasa Yamauchi (Tokyo University, Japan )  
14:30 - 16:00 Symposium V: Inflammatory Mediators
ÁÂÀå: Àå¾ç¼ö (¿¬¼¼ÀÇ´ë), ±èÈ¿¼ö (¼­¿ïÀÇ´ë)  
14:30 - 14:48 Genetics in vascular diseases
¹ÚÇö¿µ (±¹¸³º¸°Ç¿¬±¸¿ø)  
14:48 - 15:06 Atherogenic risk factors ; update
Á¶»óÈ£ (ÇѸ²ÀÇ´ë)  
15:06 - 15:24 Inflammation and lipoprotein metabolism
±è»óÇö (¼­¿ïÀÇ´ë)  
15:24 - 15:42 Macrophages in Atherosclerosis
ÇѱâÈÆ (¿ï»êÀÇ´ë)  
15:42 - 16:00 Q&A
Panel: ±èÀ念, ±èµ¿¿î, ÀÓµµ¼±  
16:00 - 16:30 Coffee Break - Æ÷½ºÅÍ ±¸¿¬
16:30 - 18:00 Symposium VI: Epidemiology in Atherosclerosis
ÁÂÀå: ±èÄ¡Á¤ (Áß¾ÓÀÇ´ë), ÃÖµ¿ÁÖ (¼­¿ïÀÇ´ë)  
16:30 - 16:48 Metabolic Syndrome, Diabetes, and Cardiovascular Disease: Perspectives from the National
Health and Nutrition Examination Survey and Other Population Studies
Nathan D. Wong (University of California in Irvine, USA)  
16:48 - 17:06 Çѱ¹ÀÎ ½ÖµÕÀÌ-°¡Á· ÄÚȣƮ¿Í ½ÉÇ÷°ü°èÁúȯ ¹× ´ë»ç¼ºÁõÈıº°ü·Ã À¯Àüü ÀÚ·á¿ø ¼Ò°³
¼ºÁÖÇå (¼­¿ïÀÇ´ë)  
17:06 - 17:24 Trends, methods and results of recent clinical researches: Framingham Herat Study
³²º´È£ (±¹¸³¾Ï¼¾ÅÍ)  
17:24 - 17:42 ½ÉÇ÷°üÁúȯ À§Çèµµ ¿¹Ãø°ú ºñ¸¸ÁöÇ¥(Obesity index in prediction of cardiovascular disease risk)
¹Ú¼ºÈñ (±¹¸³º¸°Ç¿¬±¸¿ø)  
17:42 - 18:00 Q&A
Panel: Áö¼±ÇÏ, ±èÁÖÇÑ, ¼ºÁöµ¿  
18:00 - 18:10 ½Ã»ó ¹× Æóȸ½Ä
Á¤ÇåÅà ȸÀå / ÃÖµ¿ÁÖ ÇмúÀ§¿øÀå  
08:30 - 09:00 µî·Ï
09:00 - 10:30 Oral presentation-1
ÁÂÀå: 伺ö (°æºÏÀÇ´ë), Á¤¸íÈ£ (Àü³²ÀÇ´ë)  
10:30 - 11:00 Coffee Break - Æ÷½ºÅÍ ±¸¿¬
11:00 - 12:30 Oral presentation-2
ÁÂÀå: ¹é»óÈ« (°¡Å縯ÀÇ´ë), ³²¹®¼® (ÀÎÇÏÀÇ´ë)  
12:30 - 13:30 Luncheon Session
ÁÂÀå: ¹é»óÈ« (°¡Å縯ÀÇ´ë)  
12:30 - 13:30 Àû±ØÀûÀÎ ÁöÁú Á¶ÀýÀÇ ´ë»ó
ÇѱâÈÆ (¿ï»êÀÇ´ë)  
13:30 - 13:50 Coffee Break - Æ÷½ºÅÍ ±¸¿¬
13:50 - 14:30 Plenary Lecture
ÁÂÀå: ¹Ú¿µ¹è (¼­¿ïÀÇ´ë)   
13:50 - 14:30 Adiponectin and atherosclerosis
Toshimasa Yamauchi (Tokyo University, Japan )  
14:30 - 16:15 À¯°üÇÐȸ Åä·Ðȸ - ÀÌ»óÁöÁúÇ÷ÁõÀÇ Ä¡·á
ÁÂÀå: À̹®±Ô (¼º±Õ°üÀÇ´ë), ¹é»óÈ« (°¡Å縯ÀÇ´ë)   
14:30 - 15:30 I. The management of dyslipidemia: Targeting LDL cholesterol
14:30 - 14:45 ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÁöħ
¼ºÁöµ¿ (¼º±Õ°üÀÇ´ë)   
14:45 - 14:55 Proper target for patients with diabetes
¿ìÁ¤Åà (´ëÇÑ´ç´¢º´ÇÐȸ)  
14:55 - 15:05 Proper target for lowering LDL cholesterol in management of previous stroke patients
À̽ÂÈÆ (´ëÇѽŰæ°úÇÐȸ)  
15:05 - 15:15 Proper management of dyslipidemia in patients with renal disease
䵿¿Ï (´ëÇѽÅÀåÇÐȸ)  
15:15 - 15:30 Panel discussion
15:30 - 16:15 II. The management of dyslipdiemia: Beyond LDL cholesterol
15:30 - 15:40 Triglycerides and non HDL cholesterol
Á¶¼ºÈñ (Çѱ¹¿µ¾çÇÐȸ)  
15:40 - 15:50 Proper management of TG & non HDL cholesterol
ÃÖ¼ºÈñ (Çѱ¹ÁöÁúµ¿¸Æ°æÈ­ÇÐȸ)  
15:50 - 16:00 Lipoprotein particle number and size
Á¶È«±Ù (°³¿øÀÇ)  
16:00 - 16:15 Panel discussion
* ¿ÃÇغÎÅÍ ½Å¼³µÈ Poster PresentationÀº 9¿ù 5ÀÏ(Åä) Coffee Break ½Ã°£¿¡ ½ÃÇàÇÕ´Ï´Ù.